Subject: CNAB Showcases Multiple Revenue Streams in New Interview

SCV Client Spotlight
CNAB Showcases Multiple Revenue Streams in New Interview
Hot Stock to WatchHot Stock to Watch

Company: United Cannabis Corp. (OTCQB: CNAB)

End of Day:

Price: 0.95

Change (%): - 0.065 (6.40)

Volume: 87,802
CNAB Chart

United Cannabis Corp. Provides Business Update in New Interview With

AUSTIN, Texas, Sept. 30, 2014 (GLOBE NEWSWIRE) -, Inc. announced today that a new audio interview with United Cannabis Corp. (OTCQB:CNAB), a leader in the medical cannabis industry by offering patient driven solutions intent on improving biomedical and pharmaceutical pursuits thru the use of Cannabis based research, products and services., is now available. The interview with the Company’s President and Chairman Earnest Blackmon can be heard at

Earnest Blackmon, called in to to discuss the Company’s business and recent announcements, including an overview of the management team, an outlook for 2014-2015, and a review of the major milestones for the Company in 2014.

Continue Reading

Top PerformerYesterday's Top Performer

Terra Tech Corp (OTCQB: TRTC)

End of Day:

Price: 0.37

Change (%): + 0.0492 (15.34)

Volume: 2,671,262
TRTC Chart

About Terra Tech Corp

Terra Tech Corp. (OTCBB: TRTC) through its wholly-owned subsidiary GrowOp Technology, specializes in controlled environment agricultural technologies. The company integrates best-of-breed hydroponic equipment with proprietary software and hardware to provide sustainable solutions for indoor agriculture enterprises and home practitioners. Our complete product line is available at specialty retailers throughout the United States, and via our website. Through its wholly-owned subsidiary Edible Garden, cultivates a premier brand of local and sustainably grown hydroponic produce, sold through major grocery stores such as Shoprite, Food Emporium and others throughout New Jersey, New York, Delaware, Maryland, Connecticut, and Pennsylvania.

Company Information Sheet

Other Small Cap News

Company: Arch Therapeutics, Inc. (OTCQB: ARTH)

Arch Therapeutics Will Present at the Livingston Securities Life Sciences Stakeholders Summit on October 1, 2014

WELLESLEY, MA--(Marketwired - Sep 30, 2014) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of the AC5 Surgical Hemostat™, announced that it will be featured as a presenting company at the 7th Annual Livingston Securities Life Sciences Stakeholders Summit on October 1, 2014 at the Cira Center in Philadelphia, PA.

Chief Executive Officer, Terrence W. Norchi, MD, will provide a corporate overview and update. Dr. Norchi will also discuss the importance of developing a hemostatic agent that is effective in patients prescribed anti-coagulant or anti-platelet therapy, which are commonly known as blood thinners and are taken by millions of Americans.

Continue Reading

Company: Inergetics, Inc. (OTCBB: NRTI)

Inergetics Introduces Surgex® Warrior Sports Nutrition at Winn-Dixie

Surgex Warrior Exemplifies Company's Commitment to Product Excellence

NEWARK, N.J., Sept. 30, 2014 /PRNewswire/ -- Inergetics, Inc. (OTCBB: NRTI), the leading developer of nutritional supplements, today announced that Surgex® Warrior Sports Nutrition, the preferred nutritional supplements of ARMY Sports, is now available at Winn-Dixie's 700+ locations in the United States.

Packed with next generation nutraceuticals and whole food extracts, Surgex Warrior is designed to deliver positive effects on muscle growth, strength and post workout recovery.

Continue Reading

Market News

By Lee Brodie: CNBC

Cramer: Stealth catalyst behind market fits

If you're putting money to work in stocks, you might want to invest in nausea medicine, too. Jim Cramer thinks you're looking at a period of fits and starts, something not seen in the market for quite some time.

For example, on Monday the benchmark S&P 500 index posted 13 new 52-week highs and 12 new lows while the Nasdaq Composite recorded 35 new highs and 122 new lows. Meanwhile, the CBOE Volatility Index, a widely cited measure of volatility, has surged more than 30 percent in about a month.

Although it would seem that overseas events ranging from protests in Hong Kong and tensions in Russia to violence in the Middle East are driving declines, Cramer says that's not entirely the case. He thinks there's also something else going on, and it could ruin your profit potential unless you understand what's happening and how it impacts your stocks.

Continue Reading

By Manuel Schiffres:

How to Survive the Next Stock Market Correction

The secret to keeping your investment portfolio intact during a big sell-off is planning ahead and avoiding panic.

Stock market corrections are an inevitable part of investing. Since 1932, declines of 10% to 20% have occurred every two years, on average. The physics of the stock market haven’t changed today: What goes up can’t go up forever.

So what do you do if there’s a big drop in stock prices? If you believe the bull market has more room to run, don’t panic when it stumbles. There are a number of ways to put a downturn to good use.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks